Breaking News Instant updates and real-time market news.

APTO

Aptose Biosciences

$3.49

-0.16 (-4.38%)

07:07
07/10/18
07/10
07:07
07/10/18
07:07

Aptose Biosciences, CrystalGenomics announce issuance of patent for CG-806

Aptose Biosciences announced that the Japan Patent Office has issued Japanese Patent No. 6325573 for CG-806. The granted patent claims various compounds, including the CG-806 compound, pharmaceutical compositions comprising the CG-806 compound, and uses for the treatment of various diseases, such as cancer. The patent is expected to provide protection until the end of 2033.

APTO Aptose Biosciences
$3.49

-0.16 (-4.38%)

12/13/17
HCWC
12/13/17
NO CHANGE
Target $6
HCWC
Buy
Aptose Biosciences price target raised to $6 from $4 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Aptose Biosciences to $6 saying the company's collaborators at the American Society of Hematology annual meeting presented a broad set of preclinical data, which provides a "nice boost" to the profile of CG'806. The analyst keeps a Buy rating on Aptose.
05/07/18
05/07/18
NO CHANGE

Aptose Biosciences exercises early option for CG-806 license from CrystalGenomic
Aptose Biosciences and CrystalGenomics announced that Aptose exercised its option under the 2016 Option Agreement to exclusively license CG-806, a first-in-class, non-covalent pan-inhibitor of the Bruton's tyrosine kinase, or BTK, and FMS-like tyrosine kinase 3, or FLT3, from CrystalGenomics, Inc. CG-806 is being developed as a highly potent, oral small molecule for acute myeloid leukemia, or AML, B-Cell malignancies and other hematologic malignancies. With the early exercise of the option, Aptose owns global rights to develop and commercialize CG-806 for all indications outside of Korea and China - the Licensed Territory. The exercise triggers a payment of $2M to CrystalGenomics. CrystalGenomics is eligible for regulatory and sales milestone payments, as well as royalties on product sales in the Licensed Territory.
06/15/18
HCWC
06/15/18
NO CHANGE
Target $6
HCWC
Buy
Aptose presentation at EHA strengthens profile for CG-806, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis said the presentation made today at the EHA meeting by Aptose Biosciences strengthens the profile for CG-806 and his confidence is higher that the preclinical database generated should translate to meaningful clinical responses in AML and lymphoma patients. He maintains a Buy rating and $6 price target on Aptose shares.
06/29/18
HCWC
06/29/18
NO CHANGE
Target $8.5
HCWC
Buy
Aptose Biosciences target raised to $8.50 at H.C. Wainwright after hold lifted
H.C. Wainwright analyst Joseph Pantginis raised his price target on Aptose Biosciences to $8.50 from $6.00 after the FDA lifted the clinical hold on APTO-253, stating that he believes the company has two potentially first-in and best-in class drugs for the treatment of hematological malignancies with that one and CG-806. He maintains a Buy rating on Aptose Biosciences shares, which are up 17c, or 4.5%, to $3.95 in early trading.

TODAY'S FREE FLY STORIES

NTR

Nutrien

$54.54

-1.125 (-2.02%)

16:31
10/18/18
10/18
16:31
10/18/18
16:31
Upgrade
Nutrien rating change  »

Nutrien upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MU

Micron

$41.30

-1.06 (-2.50%)

, INTC

Intel

$44.98

-0.92 (-2.00%)

16:31
10/18/18
10/18
16:31
10/18/18
16:31
Hot Stocks
Micron intends to acquire remaining interest in IM Flash JV for about $1.5B »

Micron (MU) announced…

MU

Micron

$41.30

-1.06 (-2.50%)

INTC

Intel

$44.98

-0.92 (-2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

, ZEN

Zendesk

$61.68

-1.29 (-2.05%)

16:31
10/18/18
10/18
16:31
10/18/18
16:31
Hot Stocks
Stitch Fix adds Mikkel Svane to Board of Directors »

Stitch Fix (SFIX)…

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

ZEN

Zendesk

$61.68

-1.29 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

  • 06

    Dec

SYMC

Symantec

$19.97

-0.595 (-2.89%)

16:31
10/18/18
10/18
16:31
10/18/18
16:31
Initiation
Symantec initiated  »

Symantec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Dec

AAPL

Apple

$215.98

-5.22 (-2.36%)

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Initiation
Apple initiated  »

Apple initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Initiation
Qualys initiated  »

Qualys initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Initiation
Darden initiated  »

Darden initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$145.51

-2.76 (-1.86%)

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Initiation
VMware initiated  »

VMware initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Dec

XOG

Extraction Oil & Gas

$10.49

-0.3 (-2.78%)

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Hot Stocks
Extraction Oil & Gas sees Q3 average net sales volume of 75.7K BOE/d »

Sees FY18 production of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ADBE

Adobe

$250.46

-8.44 (-3.26%)

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Initiation
Adobe initiated  »

Adobe initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/18/18
10/18
16:30
10/18/18
16:30
Options
Preliminary option volume of 23.8M today »

Preliminary option volume…

VLO

Valero

$103.31

-0.36 (-0.35%)

, VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

16:29
10/18/18
10/18
16:29
10/18/18
16:29
Hot Stocks
Valero to acquire Valero Energy Partners for $42.25 per common unit in cash »

Valero Energy Corporation…

VLO

Valero

$103.31

-0.36 (-0.35%)

VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 25

    Oct

INAP

Internap

$11.00

-0.8 (-6.78%)

16:28
10/18/18
10/18
16:28
10/18/18
16:28
Syndicate
Internap files to sell common stock, no amount given »

Jefferies and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Nov

CBRL

Cracker Barrel

$155.12

-2.31 (-1.47%)

16:28
10/18/18
10/18
16:28
10/18/18
16:28
Initiation
Cracker Barrel initiated  »

Cracker Barrel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRA

Natera

$21.40

0.09 (0.42%)

, NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
Natera, Neon Therapeutics announce clinical trial collaboration for NEO-PV-01 »

Natera (NTRA) and Neon…

NTRA

Natera

$21.40

0.09 (0.42%)

NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

MRK

Merck

$72.22

0.42 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

CBS

CBS

$56.17

0.3 (0.54%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
CBS names David Nevins as Chief Creative Officer »

David Nevins has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

, WMT

Walmart

$96.19

-0.37 (-0.38%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
Stitch Fix promotes Mike Smith to COO and President »

On October 16, the Board…

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

WMT

Walmart

$96.19

-0.37 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 13

    Nov

  • 15

    Nov

CBS

CBS

$56.17

0.3 (0.54%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
CBS names Christina Spade CFO »

Christina Spade has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CMG

Chipotle

$431.72

2.09 (0.49%)

16:26
10/18/18
10/18
16:26
10/18/18
16:26
Initiation
Chipotle initiated  »

Chipotle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRA

Natera

$21.40

0.09 (0.42%)

, NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

16:25
10/18/18
10/18
16:25
10/18/18
16:25
Hot Stocks
Natera and Neon Therapeutics collaborate on cancer vaccine trial »

Natera (NTRA) and Neon…

NTRA

Natera

$21.40

0.09 (0.42%)

NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

MRK

Merck

$72.22

0.42 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

CTXS

Citrix

$103.40

-1.73 (-1.65%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
Citrix initiated  »

Citrix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

DOCU

DocuSign

$46.26

-1.305 (-2.74%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MSFT

Microsoft

$108.54

-2.18 (-1.97%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
Microsoft initiated  »

Microsoft initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

CAKE

Cheesecake Factory

$50.32

-0.79 (-1.55%)

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 14

    Nov

MYL

Mylan

$32.42

-0.61 (-1.85%)

, PFE

Pfizer

$44.02

-0.55 (-1.23%)

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Hot Stocks
Mylan announces U.S. launch of generic Depo-Provera »

Mylan (MYL) announced the…

MYL

Mylan

$32.42

-0.61 (-1.85%)

PFE

Pfizer

$44.02

-0.55 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.